MAPIX
Price
$16.99
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Net Assets
560M
MPACX
Price
$27.59
Change
-$0.01 (-0.04%)
Updated
Oct 17 closing price
Net Assets
219.93M
Interact to see
Advertisement

MAPIX vs MPACX

Header iconMAPIX vs MPACX Comparison
Open Charts MAPIX vs MPACXBanner chart's image
Matthews Asia Dividend Investor
Price$16.99
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets560M
Matthews Asia Growth Investor
Price$27.59
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets219.93M
MAPIX vs MPACX Comparison Chart in %
View a ticker or compare two or three
VS
MAPIX vs. MPACX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPIX is a Hold and MPACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MAPIX has more cash in the bank: 560M vs. MPACX (220M). MAPIX pays higher dividends than MPACX: MAPIX (2.71) vs MPACX (1.91). MAPIX was incepted earlier than MPACX: MAPIX (19 years) vs MPACX (22 years). MPACX (1.25) and MAPIX (1.20) have similar cost to investors . MPACX is a more actively managed with annual turnover of: 184.44 vs. MAPIX (16.81). MAPIX (2500) and MPACX (2500) have matching initial minimum investment requirements. MPACX annual gain was more profitable for investors over the last year : 16.71 vs. MAPIX (15.53). MAPIX return over 5 years is better than : -9.81 vs. MPACX (-15.06).
MAPIXMPACXMAPIX / MPACX
Total Expense Ratio1.201.2596%
Annual Report Gross Expense Ratio1.201.2596%
Fund Existence19 years22 years-
Gain YTD22.07123.22595%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets560M220M255%
Annual Yield % from dividends2.711.91142%
Returns for 1 year15.5316.7193%
Returns for 3 years44.9247.8594%
Returns for 5 years-9.81-15.0665%
Returns for 10 years28.0244.5963%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THISX85.260.35
+0.41%
T. Rowe Price Health Sciences I
FSCZX29.22N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val Z
FRIEX20.46N/A
N/A
Federated Hermes Emerging Markets Eq R6
AIECX20.02-0.03
-0.15%
Invesco EQV International Equity C
AINIX17.73-0.06
-0.34%
Ariel International Institutional